Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The Future of Immune Checkpoint Cancer Therapy After PD-1 and CTLA-4
HTML
Details
Locations
Year:
2017
Type:
review
Source:
Immunotherapy
DOI:
10.2217/imt-2017-0024
Authors:
Andrew W Hahn,
David M Gill,
Sumanta K Pal,
Neeraj Agarwal
Institutions:
University of Utah,
City Of Hope National Medical Center,
City of Hope,
Huntsman Cancer Institute
Language:
English
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
immune checkpoint inhibitors,
PD-1,
CTLA-4,
co-inhibitory receptors,
costimulatory receptors,
TNF receptor superfamily,
monoclonal antibodies,
cancer immunotherapy,
combination therapy,
T cell signaling,
tumor immunology
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2728903533
FWCI:
1.423
Cites:
115
Cited by:
124
Related to:
10